Occudo Quantitative Strategies’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-41,944
Closed -$50.3K 1375
2023
Q1
$50.3K Buy
+41,944
New +$93.3K ﹤0.01% 849
2022
Q4
Sell
-65,149
Closed -$159K 1494
2022
Q3
$159K Sell
65,149
-70,770
-52% -$236K 0.01% 990
2022
Q2
$309K Buy
+135,919
New +$506K 0.03% 784

Other funds holding DBD

Occudo Quantitative Strategies's DBD Position: Q2 2023 in Review

Occudo Quantitative Strategies sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2023, closing a stake of 41,944 shares — an estimated $50.3K sold.

Occudo Quantitative Strategies first reported a position in DBD in Q2 2022 and held it in 3 quarters. The position peaked at $309K in Q2 2022. 7 funds tracked by Wall St. Rank hold DBD as of Q2 2023.

  • Occudo Quantitative Strategies reported no remaining Diebold Nixdorf Incorporated position as of Q2 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 41,944 Diebold Nixdorf Incorporated shares in Q2 2023, an estimated $50.3K.
  • Occudo Quantitative Strategies first reported a position in Diebold Nixdorf Incorporated in Q2 2022 and held it in 3 quarters.
  • Occudo Quantitative Strategies's Diebold Nixdorf Incorporated position peaked at $309K in Q2 2022.
  • 7 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.